A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
Links shared publicly online about this topic.
- 99total visits
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
bloodjournal.hematologylibrary.org —
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605
View full resource at bloodjournal.hematologylibrary.org
Tags: Leukemia, Acute Myelogenous Leukemia, Phase 2 Clinical Trial, Oncology
Most Recently Shared on August 3, 2011 at 3:16 pm By:
http://bloodjournal.hematologylibrary.org/content/118/3/523.abstract?sid=963295ad-24bf-4b40-85e7-f417f8a657b0 Len... http://fb.me/BicxwtQq
Advertisement
